This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2001 Jun 30;322(7302):1596-8.

doi: 10.1136/bmj.322.7302.1596.

Summarising economic evaluations in systematic reviews: a new approach

J Nixon¹, K S Khan, J Kleijnen

Affiliations

PMID: 11431306
PMCID: PMC1120631
DOI: 10.1136/bmj.322.7302.1596

Summarising economic evaluations in systematic reviews: a new approach

J Nixon et al. BMJ. 2001.

. 2001 Jun 30;322(7302):1596-8.

doi: 10.1136/bmj.322.7302.1596.

Authors

J Nixon¹, K S Khan, J Kleijnen

Affiliation

¹ NHS Centre for Reviews and Dissemination, University of York, York YO10 5DD. jn105@york.ac.uk

PMID: 11431306
PMCID: PMC1120631
DOI: 10.1136/bmj.322.7302.1596

No abstract available

PubMed Disclaimer

Figures

Figure 1
Permutation matrix for possible outcomes of economic evaluations for study of intervention v comparator. In the original matrix numbers were used instead of letters

Figure 2
Permutation plots summarising findings of economic evaluations for intervention v comparator. Numbers in cells are number of studies relevant to each permutation

Figure 3
Hierarchical matrix used to summarise findings of economic evaluations for intervention v comparator. Numbers in cells are number of studies relevant to each permutation

See this image and copyright information in PMC

Similar articles

Systematic reviews of economic evaluations: utility or futility?
Anderson R. Anderson R. Health Econ. 2010 Mar;19(3):350-64. doi: 10.1002/hec.1486. Health Econ. 2010. PMID: 19378354
Conducting systematic reviews of economic evaluations.
Gomersall JS, Jadotte YT, Xue Y, Lockwood S, Riddle D, Preda A. Gomersall JS, et al. Int J Evid Based Healthc. 2015 Sep;13(3):170-8. doi: 10.1097/XEB.0000000000000063. Int J Evid Based Healthc. 2015. PMID: 26288063
[From a herd of sheep to pharmacoeconomics].
Bias R. Bias R. Wien Med Wochenschr. 2000;150(15-16):348-9. Wien Med Wochenschr. 2000. PMID: 11105331 German. No abstract available.
Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018.
Watts RD, Li IW. Watts RD, et al. Value Health. 2019 Mar;22(3):377-382. doi: 10.1016/j.jval.2018.10.006. Epub 2018 Dec 14. Value Health. 2019. PMID: 30832977 Review.
Endocrine therapy in ovarian cancer: where do we stand?
Paleari L, DeCensi A. Paleari L, et al. Curr Opin Obstet Gynecol. 2018 Feb;30(1):17-22. doi: 10.1097/GCO.0000000000000423. Curr Opin Obstet Gynecol. 2018. PMID: 29176513 Review.

See all similar articles

Cited by

Head-to-head comparison of the costs of atypical antipsychotics: a systematic review.
Barbui C, Lintas C, Percudani M. Barbui C, et al. CNS Drugs. 2005;19(11):935-50. doi: 10.2165/00023210-200519110-00004. CNS Drugs. 2005. PMID: 16268665
Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review.
van Steenbergen-Weijenburg KM, van der Feltz-Cornelis CM, Horn EK, van Marwijk HW, Beekman AT, Rutten FF, Hakkaart-van Roijen L. van Steenbergen-Weijenburg KM, et al. BMC Health Serv Res. 2010 Jan 19;10:19. doi: 10.1186/1472-6963-10-19. BMC Health Serv Res. 2010. PMID: 20082727 Free PMC article.
Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review.
Cook DA, Stephenson CR, Wilkinson JM, Maloney S, Foo J. Cook DA, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2144973. doi: 10.1001/jamanetworkopen.2021.44973. JAMA Netw Open. 2022. PMID: 35080604 Free PMC article.
Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study.
Jacobsen E, Boyers D, Avenell A. Jacobsen E, et al. Pharmacoeconomics. 2020 Mar;38(3):259-267. doi: 10.1007/s40273-019-00878-2. Pharmacoeconomics. 2020. PMID: 31930461 Free PMC article. Review.
Systematic meta-review of supported self-management for asthma: a healthcare perspective.
Pinnock H, Parke HL, Panagioti M, Daines L, Pearce G, Epiphaniou E, Bower P, Sheikh A, Griffiths CJ, Taylor SJ; PRISMS and RECURSIVE groups. Pinnock H, et al. BMC Med. 2017 Mar 17;15(1):64. doi: 10.1186/s12916-017-0823-7. BMC Med. 2017. PMID: 28302126 Free PMC article.

See all "Cited by" articles

References

1. NHS Executive. London: NHS Executive; 1999. Faster access to modern treatment: how NICE appraisal will work.
1. Nixon J, Stoykova B, Christie J, Glanville JM, Drummond MF, Kleijnen J. The UK NHS economic evaluation database: economic issues in evaluations of health technology. Int J Health Technol Assess. 2000;16:1–12. - PubMed
1. Nixon J, Stoykova B, Christie J, Glanville JM, Kleijnen J, Drummond MF. NHS economic evaluation database for healthcare decision makers. BMJ. 2000;321:32. - PMC - PubMed
1. NHS Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness. CRD's guidance for carrying out or commissioning reviews. 2nd ed. York: NHS Centre for Reviews and Dissemination; 2000.
1. Black WC. The CE plane: a graphic representation of cost-effectiveness. Med Decis Making. 1990;10:212–214. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources